C. Frank Bennett

C. Frank Bennett, listed as senior executive, appears in our data through filings on Ionis Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 43 filings, for trades running from 1 January 2016 to 7 July 2026.

Every open-market trade on record is a sale: 13 sales worth €4.4M. No amount is published for 4 filings, which the totals therefore leave out. Other entries cover 4 share grants and 13 option exercises. In 2026 alone, the filings show no purchases and 4 sales.

The latest filing, published on 9 July 2026, reports a transaction in Ionis Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.